Failure of high-dose daptomycin for bacteremia caused by daptomycin-susceptible enterococcus faecium harboring liasr substitutions

Jose M. Munita; Nagendra N. Mishra; Danya Alvarez; Truc T. Tran; Lorena Diaz; Diana Panesso; Jinnethe Reyes; Barbara E. Murray; Javier A. Adachi; Arnold S. Bayer; Cesar A. Arias

doi:10.1093/cid/ciu642

Failure of high-dose daptomycin for bacteremia caused by daptomycin-susceptible enterococcus faecium harboring liasr substitutions

Jose M. Munita, Nagendra N. Mishra, Danya Alvarez, Truc T. Tran, Lorena Diaz, Diana Panesso, Jinnethe Reyes, Barbara E. Murray, Javier A. Adachi, Arnold S. Bayer, Cesar A. Arias

Infectious Diseases, Infection Control, and Employee Health

Research output: Contribution to journal › Article › peer-review

55 Scopus citations

Abstract

High-dose daptomycin (DAP) therapy failed in a neutropenic patient with bloodstream infection caused by a DAP-susceptible Enterococcus faecium (minimum inhibitory concentration, 3 μg/mL) harboring genetic changes associated with DAP resistance, with persistent bacteremia and selection of additional resistances. Daptomycin monotherapy should be used cautiously against DAP-susceptible E. faecium strains with minimum inhibitory concentrations 2 g/mL.

Original language	English (US)
Pages (from-to)	1277-1280
Number of pages	4
Journal	Clinical Infectious Diseases
Volume	59
Issue number	9
DOIs	https://doi.org/10.1093/cid/ciu642
State	Published - Nov 1 2014

Keywords

Daptomycin
Enterococcus faecium
resistance
treatment failure

ASJC Scopus subject areas

Microbiology (medical)
Infectious Diseases

Access to Document

10.1093/cid/ciu642

Cite this

Munita, J. M., Mishra, N. N., Alvarez, D., Tran, T. T., Diaz, L., Panesso, D., Reyes, J., Murray, B. E., Adachi, J. A., Bayer, A. S., & Arias, C. A. (2014). Failure of high-dose daptomycin for bacteremia caused by daptomycin-susceptible enterococcus faecium harboring liasr substitutions. Clinical Infectious Diseases, 59(9), 1277-1280. https://doi.org/10.1093/cid/ciu642

@article{7f6b5c0d42a648e0b95c056ba07258a0,

title = "Failure of high-dose daptomycin for bacteremia caused by daptomycin-susceptible enterococcus faecium harboring liasr substitutions",

abstract = "High-dose daptomycin (DAP) therapy failed in a neutropenic patient with bloodstream infection caused by a DAP-susceptible Enterococcus faecium (minimum inhibitory concentration, 3 μg/mL) harboring genetic changes associated with DAP resistance, with persistent bacteremia and selection of additional resistances. Daptomycin monotherapy should be used cautiously against DAP-susceptible E. faecium strains with minimum inhibitory concentrations 2 g/mL.",

keywords = "Daptomycin, Enterococcus faecium, resistance, treatment failure",

author = "Munita, {Jose M.} and Mishra, {Nagendra N.} and Danya Alvarez and Tran, {Truc T.} and Lorena Diaz and Diana Panesso and Jinnethe Reyes and Murray, {Barbara E.} and Adachi, {Javier A.} and Bayer, {Arnold S.} and Arias, {Cesar A.}",

note = "Publisher Copyright: {\textcopyright} 2014 The Author.",

year = "2014",

month = nov,

day = "1",

doi = "10.1093/cid/ciu642",

language = "English (US)",

volume = "59",

pages = "1277--1280",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

number = "9",

}

TY - JOUR

T1 - Failure of high-dose daptomycin for bacteremia caused by daptomycin-susceptible enterococcus faecium harboring liasr substitutions

AU - Munita, Jose M.

AU - Mishra, Nagendra N.

AU - Alvarez, Danya

AU - Tran, Truc T.

AU - Diaz, Lorena

AU - Panesso, Diana

AU - Reyes, Jinnethe

AU - Murray, Barbara E.

AU - Adachi, Javier A.

AU - Bayer, Arnold S.

AU - Arias, Cesar A.

PY - 2014/11/1

Y1 - 2014/11/1

N2 - High-dose daptomycin (DAP) therapy failed in a neutropenic patient with bloodstream infection caused by a DAP-susceptible Enterococcus faecium (minimum inhibitory concentration, 3 μg/mL) harboring genetic changes associated with DAP resistance, with persistent bacteremia and selection of additional resistances. Daptomycin monotherapy should be used cautiously against DAP-susceptible E. faecium strains with minimum inhibitory concentrations 2 g/mL.

AB - High-dose daptomycin (DAP) therapy failed in a neutropenic patient with bloodstream infection caused by a DAP-susceptible Enterococcus faecium (minimum inhibitory concentration, 3 μg/mL) harboring genetic changes associated with DAP resistance, with persistent bacteremia and selection of additional resistances. Daptomycin monotherapy should be used cautiously against DAP-susceptible E. faecium strains with minimum inhibitory concentrations 2 g/mL.

KW - Daptomycin

KW - Enterococcus faecium

KW - resistance

KW - treatment failure

UR - http://www.scopus.com/inward/record.url?scp=84907049035&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907049035&partnerID=8YFLogxK

U2 - 10.1093/cid/ciu642

DO - 10.1093/cid/ciu642

M3 - Article

C2 - 25107294

AN - SCOPUS:84907049035

SN - 1058-4838

VL - 59

SP - 1277

EP - 1280

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - 9

ER -

Failure of high-dose daptomycin for bacteremia caused by daptomycin-susceptible enterococcus faecium harboring liasr substitutions

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this